REPLIGEN CORP - COMMON STOCK (RGEN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RGEN on Nasdaq
CUSIP
759916109
Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
59.8M
Holdings value
$7.99B
% of all portfolios
0.008%
Grand Portfolio weight change
+0%
Number of holders
443
Number of buys
231
Number of sells
-214
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REPLIGEN CORP - COMMON STOCK (RGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.3% $725M 5.2M BlackRock, Inc. Mar 31, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 6.1% -50.8% $436M -$471M 3.43M -51.9% T. Rowe Price Associates, Inc. Aug 31, 2025
EDDLEMAN ROY T 4.84% $377M 2.71M Roy T. Eddleman Living Trust Dec 31, 2024

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59.8M $7.99B +$241M $133.67 443
2025 Q2 58M $7.22B +$69M $124.38 441
2025 Q1 57.4M $7.3B +$139M $127.24 438
2024 Q4 56.2M $8.09B +$126M $143.94 427
2024 Q3 55.3M $8.23B +$2.81M $148.82 441
2024 Q2 56.1M $7.07B -$92M $126.06 445
2024 Q1 56M $10.3B -$395M $183.92 482
2023 Q4 58.1M $10.4B +$264M $179.80 463
2023 Q3 56.8M $9.03B +$343M $159.01 434
2023 Q2 54.7M $7.74B +$95.3M $141.46 440
2023 Q1 53.8M $9.05B +$70.2M $168.36 440
2022 Q4 53.5M $9.06B +$399M $169.31 435
2022 Q3 51M $9.55B +$148M $187.11 424
2022 Q2 50.2M $8.16B +$277M $162.40 388
2022 Q1 48.7M $9.15B +$201M $188.09 430
2021 Q4 47.1M $12.5B -$237M $264.84 487
2021 Q3 47.2M $13.6B +$286M $288.99 475
2021 Q2 46.3M $9.25B +$157M $199.62 422
2021 Q1 45.7M $8.87B +$77.1M $194.41 453
2020 Q4 45.8M $8.77B +$267M $191.63 443
2020 Q3 44.7M $6.6B -$40.2M $147.54 384
2020 Q2 45.1M $5.58B -$187M $123.61 363
2020 Q1 46.5M $4.48B +$298M $96.54 302
2019 Q4 43.5M $4.03B -$117M $92.50 298
2019 Q3 44.8M $3.43B -$8.49M $76.69 296
2019 Q2 44.7M $3.84B +$502M $85.95 266
2019 Q1 40.2M $2.38B +$32.8M $59.08 244
2018 Q4 39.8M $2.1B -$117M $52.74 238
2018 Q3 41.8M $2.32B +$69.4M $55.46 199
2018 Q2 40.6M $1.91B +$107M $47.04 191
2018 Q1 38.6M $1.4B +$29.2M $36.18 184
2017 Q4 37.9M $1.37B +$48.5M $36.28 180
2017 Q3 36.4M $1.4B +$28.8M $38.32 191
2017 Q2 35.6M $1.47B +$152M $41.44 200
2017 Q1 32.5M $1.14B +$158M $35.20 182
2016 Q4 32.3M $995M +$13.4M $30.82 183
2016 Q3 31.9M $963M +$47.8M $30.19 177
2016 Q2 30.4M $833M +$19.4M $27.36 181
2016 Q1 29.6M $794M +$36.1M $26.82 180
2015 Q4 28.5M $807M -$43.3M $28.29 173
2015 Q3 30.1M $838M -$17.5M $27.85 187
2015 Q2 30.3M $1.25B +$37.4M $41.27 174
2015 Q1 29.6M $898M +$25M $30.36 170
2014 Q4 29.1M $577M +$25.2M $19.80 165
2014 Q3 28.1M $560M -$3.54M $19.91 165
2014 Q2 28.1M $641M +$57M $22.79 165
2014 Q1 26.5M $343M +$11.7M $12.86 139